Glenmark Pharma Beats Suit Over Recalled Cholesterol Drugs

By Rae Ann Varona · June 17, 2026, 6:47 PM EDT

A New Jersey federal judge Wednesday tossed a proposed class action that accused drugmaker Glenmark Pharmaceuticals of falsely representing that its statin cholesterol drugs were safe and effective despite a recall...

To view the full article, register now.

Documents

Case Information

Case Title

CHAMBERS et al v. GLENMARK PHARMACEUTICALS INC.

Case Number

2:25-cv-02984

Court

New Jersey

Nature of Suit

Contract: Other

Date Filed

April 22, 2025